Anthrax Toxins Induce Shock in Rats by Depressed Cardiac Ventricular Function
Open Access
- 23 May 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (5) , e466
- https://doi.org/10.1371/journal.pone.0000466
Abstract
Anthrax infections are frequently associated with severe and often irreversible hypotensive shock. The isolated toxic proteins of Bacillus anthracis produce a non-cytokine-mediated hypotension in rats by unknown mechanisms. These observations suggest the anthrax toxins have direct cardiovascular effects. Here, we characterize these effects. As a first step, we administered systemically anthrax lethal toxin (LeTx) and edema toxin (EdTx) to cohorts of three to twelve rats at different doses and determined the time of onset, degree of hypotension and mortality. We measured serum concentrations of the protective antigen (PA) toxin component at various time points after infusion. Peak serum levels of PA were in the µg/mL range with half-lives of 10–20 minutes. With doses that produced hypotension with delayed lethality, we then gave bolus intravenous infusions of toxins to groups of four to six instrumented rats and continuously monitored blood pressure by telemetry. Finally, the same doses used in the telemetry experiments were given to additional groups of four rats, and echocardiography was performed pretreatment and one, two, three and twenty-four hours post-treatment. LeTx and EdTx each produced hypotension. We observed a doubling of the velocity of propagation and 20% increases in left ventricular diastolic and systolic areas in LeTx-treated rats, but not in EdTx-treated rats. EdTx-but not LeTx-treated rats showed a significant increase in heart rate. These results indicate that LeTx reduced left ventricular systolic function and EdTx reduced preload. Uptake of toxins occurs readily into tissues with biological effects occurring within minutes to hours of serum toxin concentrations in the µg/mL range. LeTx and EdTx yield an irreversible shock with subsequent death. These findings should provide a basis for the rational design of drug interventions to reduce the dismal prognosis of systemic anthrax infections.Keywords
This publication has 39 references indexed in Scilit:
- Anthrax Edema Toxin Sensitizes DBA/2J Mice to Lethal ToxinInfection and Immunity, 2007
- Bacillus anthracisEdema and Lethal Toxin Have Different Hemodynamic Effects but Function Together to Worsen Shock and Outcome in a Rat ModelThe Journal of Infectious Diseases, 2007
- Anthrax Toxin Receptor 2–Dependent Lethal Toxin Killing In VivoPLoS Pathogens, 2006
- Protective Antigen as a Correlative Marker for Anthrax in Animal ModelsInfection and Immunity, 2006
- Detection of Anthrax Toxin in the Serum of Animals Infected with Bacillus anthracis by Using Engineered ImmunoassaysClinical and Vaccine Immunology, 2006
- BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxinMolecular Cancer Therapeutics, 2005
- Anthrax edema factor potency depends on mode of cell entryBiochemical and Biophysical Research Communications, 2005
- Late Treatment with a Protective Antigen–Directed Monoclonal Antibody Improves Hemodynamic Function and Survival in a Lethal Toxin–Infused Rat Model of Anthrax SepsisThe Journal of Infectious Diseases, 2005
- Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Dose-Dependent Systemic and Regional Hemodynamic Effects of Calcitonin Gene-Related PeptideThe Lancet Healthy Longevity, 1989